HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 06, June 2018 – Cancer - Therapies and strategies for better patient outcomes       » Gardasil 9 supply running short in Hong Kong       » China helps Tajikistan tackle grassland degradation       » Immuno-oncology trials in China surge more than 50 per cent       » Yeast for industrial biotechnology       » Uncontrolled hypertension in rural communities      
INSIDE INDUSTRY
Latin American link-up aims for US$1 syphilis test
Paraguayan and Uruguayan scientists are working together to develop a US$1 diagnostic test for syphilis, which they hope can be launched as early as next year.

The early-detection kit for a disease that affects three million people in Latin America would be used alongside pregnancy tests to cut cases of congenital syphilis, say the researchers, who have linked up through the UN University's Biotechnology Programme for Latin America and the Caribbean (UNU-BIOLAC), based in Venezuela.

This program, which celebrates its 25th anniversary this year, promotes biotechnology development in the region by providing training and strengthening research, and by working with regional and international scientific and academic organisations.

At two UNU-BIOLAC training courses held in Paraguay earlier this year, scientists from Paraguay and Uruguay started to work together to purify proteins from the bacteria that causes syphilis so they can be used for diagnosis with the aim of developing a cheap test for the disease.

Mónica Marín, a biochemistry professor at the University of the Republic of Uruguay, who is involved in the research, says, "In Latin America, syphilis is not concentrated in big cities but is scattered, and it is very important to make a diagnosis and give treatment when patients arrive at a health centre."

"It is much harder to get people to return to check the result of a [test] if they have to travel long distances," she says. "The benefit of this test would be direct: once the illness is detected, the patient receives immediate treatment with penicillin, enough to avoid mother-child transmission that happens during labour."

At US$25, current commercial kits for the disease's early detection are too expensive to use for systematic screening, especially when 330,000 pregnant women a year have the disease, yet receive no treatment, resulting in 110,000 babies with congenital syphilis across Latin America.

According to Marín, the plan is to launch the test next year, but the research team needs further funding to do so.

"Having a cheap screening test for congenital syphilis will offer great scientific, social and economic value since, as well as reducing the costs of healthcare services, it will improve health status in general, avoiding future problems related to syphilis.” Doris Cardona, an epidemiologist at CES University, Colombia, says

And María De La Calle, head of the perinatal infectious diseases unit at La Paz Hospital, Spain, says: "The idea of using a diagnostic test that is carried out at the same time as a pregnancy test allows early introduction of penicillin treatment, not only preventing congenital syphilis but also first-trimester abortions.”

Marín says the UNU courses allowed the researchers to share "experiences, expectations, an overall vision of the topic, problems and possible solutions".

"Partnerships are always beneficial, and when scientists from Latin American countries work together they are sending a message to the international community about the value of regional scientists," says Cardona.

De La Calle adds: "Teamwork is essential when it comes to endemic diseases affecting an entire continent. South-South cooperation will increase efficiency in the early diagnosis of syphilis in pregnancy and it will be the first step to eliminate congenital syphilis in South America."

Source: Science Development Network

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy